2m 2m 2m 2m 2m 2m 2m
CORMEDIX (CRMD)
NASDAQ
$8.25+$0.05 (+0.62%)
Price as of Aug 21, 2026 7:56 PM EDT- $639.1MMarket Cap
- -40.10%1-Year Change
- BiotechnologyIndustry
CORMEDIX (CRMD)
$8.25+$0.05 (+0.62%)
CRMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.20 | ||
Change | -$0.03 (-0.36%) | ||
Open | $8.29 | ||
High | $8.41 | ||
Low | $8.15 | ||
Previous Close | $8.23 | ||
Volume | 1,496,715 | ||
30-Day Average Volume | 1,378,148 | ||
1-Week Change | 8.75% | ||
1-Month Change | 0.12% | ||
1-Year Change | -40.10% | ||
3-Year Change | 94.77% | ||
5-Year Change | 39.69% | ||
Fundamentals | |||
Shares Outstanding | 77.9M | ||
Total Assets | $904.1M | ||
Market Cap | $639.1M | ||
Enterprise Value | $527.6M | ||
Period: QTR TTM FY | |||
Revenue | $94.3M | ||
Net Income | $26.0M | ||
Free Cash Flow | $85.7M | ||
EBIT | $40.5M | ||
EBITDA | $51.1M | ||
Net Working Capital | $293.2M | ||
EPS | $0.29 | ||
Enterprise Value/EBITDA | 10 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | 28 | ||
PEG | -1 | ||
Price/Free Cash Flow | 7 | ||
Price/Operating Cash Flow | 7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 03/26/2019 | ||
Earnings & Revenue